U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07682298) titled 'Assessment of Residual Congestion in Acute Decompensated Heart Failure' on June 26.
Brief Summary: DESIGN:
A prospective, multicenter, observational cohort study including 580 patients admitted for acute decompensated heart failure (ADHF).
Ultrasound assessment of congestion (VExUS and LUS) will be performed serially during admission: within 48 hours of admission, at the time diuretic therapy is switched from intravenous to oral, and on the day of discharge. The discharge assessment will serve as the primary predictor.
Treating physicians will be blinded to all ultrasound findings. Patients will be followed for 90 days by telephon...